Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (957)	5/6/1999 6:24:00 AM
From: Craig A	Read Replies (1) \| Respond to of 1686

From Briefing.com this AM 'Don't let the market's reaction fool you... This is a solidly managed company with a strong product portfolio, trading at reasonable valuations... Now that the stock has pulled back and alleviated its s/t overbought technical tone, Briefing.com expects BGEN to resume its winning ways in the weeks and months ahead... BGEN trades at 37.8x estimated FY99 earnings and 31.4x projected FY00 results, with a long-term growth rate of 26.4%... Given much better than market growth potential we contend that stock should command PEG of at least 1.75... As such, we expect stock to test 120, with penetration resulting in long-term assualt on 144 area."